China Universal Asset Management Company’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,405
Closed -$84.4K 455
2023
Q4
$84.4K Buy
8,405
+6,657
+381% +$66.8K 0.02% 304
2023
Q3
$5.03K Buy
1,748
+855
+96% +$2.46K ﹤0.01% 394
2023
Q2
$3.4K Sell
893
-10
-1% -$38 ﹤0.01% 403
2023
Q1
$1.68K Buy
903
+225
+33% +$419 ﹤0.01% 436
2022
Q4
$1.56K Buy
678
+54
+9% +$124 ﹤0.01% 385
2022
Q3
$2K Buy
+624
New +$2K ﹤0.01% 373